- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Electrolytes in Australia
Total 17 results
-
Medical University of ViennaKlinik FavoritenRecruitingVolume Overload | Hyperosmolality | Electrolyte ImbalanceAustria
-
Medical University of GrazNGFI Next Generation Fluorescence Imaging GmbHCompleted
-
The Queen Elizabeth HospitalCompletedArrhythmias, Cardiac | HypokalemiaAustralia
-
Medical University of GrazB. Braun Melsungen AG; Center for Biomarker Research in MedicineCompletedAcute Kidney Injury | Electrolyte ImbalancesAustria
-
Medical University of ViennaCompletedMetabolic Acidosis | Hyperkalaemia Requiring Postoperative DialysisAustria
-
ZS Pharma, Inc.CompletedHyperkalemiaUnited States, Australia
-
ZS Pharma, Inc.CompletedHyperkalemiaUnited States, South Africa, Australia
-
ZS Pharma, Inc.CompletedHyperkalemiaUnited States, South Africa, Australia
-
ZS Pharma, Inc.CompletedHyperkalemiaUnited States, Germany, Australia, Netherlands, South Africa, Romania, United Kingdom
-
SanofiCompletedCongestive Heart FailureUnited States, Canada, Poland, Romania, Portugal, Sweden, Belgium, Argentina, Denmark, Hungary, Israel, Australia, Chile, South Africa, Greece
-
Medical University of ViennaUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Healthy Volunteers | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Familiar Hypocalcuric HypercalcemiaAustria
-
AmgenCompletedHyperparathyroidism, Primary | HypercalcemiaUnited States, Canada, Russian Federation, Hungary, Australia, Portugal, Poland
-
Vifor (International) Inc.Active, not recruitingHeart Failure | HyperkalemiaSpain, United States, United Kingdom, Italy, Switzerland, Belgium, Austria
-
AstraZenecaTerminatedHyperkalemiaUnited States, Italy, Spain, Taiwan, Thailand, Vietnam, Russian Federation, Canada, Hungary, Mexico, China, Austria, Turkey, Brazil, Germany, Poland, Czechia, United Kingdom, Bulgaria, Slovakia, Peru, Ukraine, Japan, Argentina, Malaysia, ...
-
SanofiCompletedHyponatremia | Inappropriate ADH SyndromeUnited States, France, Brazil, Russian Federation, Australia, Germany, Switzerland, Belgium, Hungary, Hong Kong, Canada
-
Calcilytix Therapeutics, Inc., a BridgeBio companyRecruitingAutosomal Dominant Hypocalcemia (ADH)United States, Australia, United Kingdom, Denmark, Italy, France, Japan, Taiwan, Canada, Czechia, Netherlands
-
Calcilytix Therapeutics, Inc., a BridgeBio companyRecruitingAutosomal Dominant HypocalcemiaUnited States, France, Denmark, Australia, Japan, Belgium, Canada, Italy, Netherlands, United Kingdom, Portugal, Finland, Germany